Top Suppliers:I want be here

1346546-69-7

1346546-69-7 structure
1346546-69-7 structure
  • Name: GSK872
  • Chemical Name: GSK-872
  • CAS Number: 1346546-69-7
  • Molecular Formula: C19H17N3O2S2
  • Molecular Weight: 383.487
  • Catalog: Signaling Pathways Apoptosis RIP kinase
  • Create Date: 2018-04-23 04:39:16
  • Modify Date: 2026-07-06 19:47:33
  • GSK'872 is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM.

Name GSK-872
Synonyms N-(6-(Isopropylsulfonyl)quinolin-4-yl)benzo[d]thiazol-5-amine
4-Quinolinamine, N-5-benzothiazolyl-6-[(1-methylethyl)sulfonyl]
GSK-872;GSK 872;GSK
GSK-872, 10 mM in DMSO
GSK'872 (GSK2399872A) ,S8465
N-(6-(Isopropylsulfonyl)quinolin-4-yl)benzo[d]thiazol-5-amine HCL SALT // GSK-872 HCL
GSK'
GSK2399872A
GSK' 872 (GSK2399872A)
RIPK3 Inhibitor, GSK′
N-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine
translocation,GSK-872,neurological,HMGB1,Rector-interacting protein kinases,brain,GSK 872,cytoplasmic,deficits,Inhibitor,edema,inhibit,RIPK,RIP kinase
GSK'872;GSK872;GSK2399872A
GSK-872 (GSK'872)
N-(6-(Isopropylsulfonyl)quinolin-4-yl)benzo[d]thiazol-5-amine HCl salt
MCE GSK-872
GSK'872
GSK'872 (GSK2399872A)
N-5-benzothiazolyl-6-[(1-methylethyl)sulfonyl]-4-Quinolinamine
GSK872, Necroptosis inhibitor
N-(1,3-Benzothiazol-5-yl)-6-(isopropylsulfonyl)-4-quinolinamine
Description GSK'872 is a RIPK3 inhibitor, which binds RIP3 kinase domain with an IC50 of 1.8 nM, and inhibits kinase activity with an IC50 of 1.3 nM.
Related Catalog
Target

RIPK3[1]

In Vitro GSK'872 blocks necroptosis in mouse cells. RIP3i GSK'872 inhibits TLR3- or DAI-induced death, two RIP1-independent pathways of necroptosis[1]. Pretreatment with GSK'872 (GSK-872) confers significant protection to primary hepatocytes. However, RIPK1 inhibition (by Nec1) does not impart any protection to primary hepatocytes[2].
Cell Assay Cell viability is estimated by Trypan blue exclusion and MTT assay. Treatment of inhibitors [N-acetyl Cysteine (NAC), butylated hydroxyanisole (BHA), IM54, Bay11-7082, Z-VAD-FMK, caspase-8 inhibitor, GSK'872 (200 nM) and necrostatin-1 (Nec-1)] is given for 4 h before Deltamethrin (DLM) treatment[2].
References

[1]. Mandal P, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell. 2014 Nov 20;56(4):481-95.

[2]. Arora D, et al. Deltamethrin induced RIPK3-mediated caspase-independent non-apoptotic cell death in rat primary hepatocytes. Biochem Biophys Res Commun. 2016 Oct 14;479(2):217-223.

Density 1.4±0.1 g/cm3
Boiling Point 625.7±55.0 °C at 760 mmHg
Molecular Formula C19H17N3O2S2
Molecular Weight 383.487
Flash Point 332.2±31.5 °C
Exact Mass 383.076202
LogP 3.10
Vapour Pressure 0.0±1.8 mmHg at 25°C
Index of Refraction 1.704
Storage condition -20℃
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.